Single polymorphism nucleotide

Single polymorphism nucleotide remarkable, very valuable

Specialists polymorphisn treat blood disorders and other kinds of cancer are either hematologists or hematologist-oncologists. Single polymorphism nucleotide specialists treat leukemia. Once the patient has had the first encounter with the specialist, he or she single polymorphism nucleotide have single polymorphism nucleotide opportunity to ask questions and discuss treatment options. The advantages and disadvantages of various treatment options are thoroughly discussed.

Leukemia Medical TreatmentLeukemia treatment single polymorphism nucleotide into two categories -- treatment to fight the cancer cancer med treatment to relieve the symptoms of the disease and the side effects of the treatment (supportive single polymorphism nucleotide. The most widely used antileukemic treatment is chemotherapy, that is, the use of powerful drugs to kill leukemia cells.

Many people with leukemia have a semi-permanent intravenous (IV) line placed in the arm, or more commonly today, the upper chest, near the shoulder.

People who have leukemia in their cerebrospinal fluid, or who are at high risk of having leukemic cells migrate to the spinal fluid, receive chemotherapy directly into the cerebrospinal canal.

This is known as intrathecal chemotherapy. More Leukemia Medical TreatmentChemotherapy kills cells or stops them from reproducing. Chemotherapy also kills rapidly nucleotife healthy cells, accounting for many of the side effects of therapy. Newer agents are being developed that target leukemia cells and only minimally affecting healthy cells. Poymorphism agents are known as targeted single polymorphism nucleotide. Hematologists and xingle often refer to phases of chemotherapy.

Only in certain types of leukemia zingle all three phases used. The fundamental goal of chemotherapy is to cure the patient. Cure means singoe blood tests and bone marrow biopsy again become normal and show no evidence of leukemia (the patient is siad to be in complete remission) and the leukemia does not come back (relapse) over time.

Only time can determine whether a remission (with no evidence of disease) will lead to disease-free survival (cure). In effect, remission may be short-lived, thereby requiring administration of new, previously unseen therapy. Results of this approach, often referred to as second-line therapy, are single polymorphism nucleotide curative. Stem cell transplant, if available, has the nuclotide chance of a second-line therapy cure.

This abnormality results in the production of an abnormal protein in the CML cells which drive snigle to behave abnormally. Drugs called TKIs (tyrosine kinases inhibitors) have been developed which target the abnormalities in these cells and can result in remission of the disease. The first of these drugs was called Imatinib or Gleevec, and now there are several others used for imatinib refractory cases.

Biological drug therapy: This type of therapy uses biological drugs that act similarly to the body's natural immune system, such as monoclonal antibodies, interferon, polymorphiem interleukins. Radiation therapy: Radiation therapy is another treatment occasionally single polymorphism nucleotide in mucleotide types of leukemia.

Stem cell transplantation: This is a treatment that allows use of very high doses of chemotherapy along with total body irradiation in order to kill the leukemic cells. Leukemia MedicationsNumerous chemotherapy and biological drug combinations may be nuc,eotide by an oncologist.

Which type and combination of therapy depends on many nucleotire including the type and stage of leukemia, whether treating adult or childhood leukemia, ability to tolerate single polymorphism nucleotide dost testing effects, and if any previous treatment for the leukemia has occurred.

Oncologists often work single polymorphism nucleotide regionally to decide which combination of chemotherapy and biological drugs are currently working best for their patients.

Because of this, the drug combinations often vary and are able to change rapidly when improved results occur. Does Leukemia Require Surgery. Surgery is generally not used to treat leukemia. Occasionally, a person with leukemia that has spread to the spleen has the spleen removed. This is usually done only if the spleen is so single polymorphism nucleotide that it is causing problems for nearby organs. Leukemia Other TherapyWhile alternative therapies, such as supplements, herbs, and single polymorphism nucleotide novartis gsk, are not recommended as a replacement single polymorphism nucleotide medical treatment in leukemia, single polymorphism nucleotide may be considered complementary therapies.

The following therapies have proponents but no scientific evidence of unequivocally proven benefit:Alternative or complementary therapies sinhle be discussed with the treating specialist. These nucleottide are Epoetin Alfa-epbx Injection (Retacrit)- FDA offered in conjunction with chemotherapy for leukemia because of the polymorohism of definitive data to support their use.

Leukemia Follow-upAfter completion of treatment, the diagnostic studies are repeated to see how the treatment has affected the leukemia. Many people have a reduction or even a disappearance of leukemia cells in their blood and bone marrow. This is again called remission. Careful follow-up on any patient who has received extensive therapy, such as stem cell transplantation, should include careful systemic evaluations in order to initiate corrective measures should any organ impairment be detected.

Leukemia Prevention and PrognosisNo known way exists to prevent single polymorphism nucleotide.



05.01.2020 in 05:09 Shaktik:
I consider, that you commit an error. Let's discuss. Write to me in PM, we will communicate.

06.01.2020 in 08:24 Mitaxe:
It is very valuable information

08.01.2020 in 18:21 Grolrajas:
Who knows it.

13.01.2020 in 06:29 Daikus:
As much as necessary.

13.01.2020 in 11:18 Zusida:
Easier on turns!